Navigation Links
ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
Date:9/3/2009

FREMONT, Calif., Sept. 3 /PRNewswire/ -- ValGenesis, Inc. today announced the worldwide availability of the vDoc360 connector for EMC Documentum v.6.5 to increase enterprise productivity specifically for regulated Pharmaceuticals, Biotech and Medical Devices companies. The vDoc360 seamlessly integrates ValGenesis with the EMC Documentum v.6.5 Server. This integration offers Documentum customers an end-to-end secured, 100% paperless validation lifecycle management solution and central storage of validation documents provided by these two complementary technologies.

This offering will seamlessly provide global access, retrieval and storage of corporate validation data and documents generated by ValGenesis within EMC Documentum v.6.5 Server. This helps to leverage real-time reporting and the robust search functionality of Documentum Server for validation data and documents.

With the vDoc360 connector for EMC Documentum, customers can extend Documentum's access control and audit capabilities to corporate validation data and documents. Furthermore, document management staff can apply federated retention policies to unify management practices across all documents and record types throughout their organizations, ensuring consistent compliance to regulatory requirements.

"Many Life Sciences companies use Documentum for document management and want the flexibility to leverage this investment. ValGenesis continues to offer state-of-the-art ValGenesis software and now allows customers to use Documentum as the central repository for validation data and documents throughout the enterprise with this integration. ValGenesis also interfaces with many other systems, including automated test engines, to leverage the power of these test engines for validation requirements. The interface with Documentum facilitates the storage of the test data and documents generated by test engines in Documentum through configurable workflow provided by ValGenesis. ValGenesis offers Documentum users strengthened return on investment and additional usability, functionality and productivity," said Siva Samy, Ph.D., ValGenesis Chief Product Strategist.

About ValGenesis

ValGenesis offers an innovative software platform that serves as the foundation for compliance-based validation life cycle management in regulated companies by enabling a 100% paperless validation process. ValGenesis is the first Enterprise application to automate the validation lifecycle and to provide 360-degree visibility to the corporate validation process. ValGenesis is designed to fully conform to FDA 21 CFR Part 11 compliance requirements. Through an industry peer review committee, the Parenteral Drug Association (PDA) awarded ValGenesis the prestigious New Innovative Technology award.

    For more information, contact:

    Mike Beaudro, 510-445-0505, mike.beaudro@valgenesis.com
    Website:http://www.valgenesis.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ValGenesis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
2. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
3. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
4. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
5. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
6. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
7. Buehler Motor, Inc., Significantly Expands Customer and Partner Support in North America
8. Providence-Based NABsys, Inc., Announces $4 Million Equity Financing
9. CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
10. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
11. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... 2016 According to a ... "Separation Systems for Commercial Biotechnology Market - Global ... 2015 - 2023", the separation systems for commercial ... in 2014 and is projected to expand at ... to reach US$ 19,227.8 Mn in 2023. ...
(Date:4/29/2016)... -- Elekta is pleased to announce that ... treatment planning software, is available for clinical release. Real-world ... version 5.11 provides significant performance speed enhancements over prior ... four times faster than in previous versions of ... Monte Carlo algorithm, users can ...
(Date:4/28/2016)... ... April 28, 2016 , ... Next week on ... on its first-in-class technologies for tissue stem cell counting and expansion to gene-editing ... to Reprogramming & CRISPR-based Genome Engineering in Burlington, Massachusetts. , The attention of ...
(Date:4/27/2016)... ... April 27, 2016 , ... Shimadzu Scientific Instruments ... Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to ... more. Expo attendees can stop by booth 1021 to learn how Shimadzu’s instruments ...
Breaking Biology Technology:
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
(Date:3/17/2016)... , March 17, 2016 ABI Research, ... forecasts the global biometrics market will reach more ... 118% increase from 2015. Consumer electronics, particularly smartphones, ... fingerprint sensors anticipated to reach two billion shipments ... Dimitrios Pavlakis , Research Analyst at ABI ...
(Date:3/15/2016)... , March 15, 2016 Yissum ... , the technology-transfer company of the Hebrew University, announced ... of remote sensing technology of various human biological indicators. ... raising $2.0 million from private investors. ... based on the detection of electromagnetic emissions from sweat ...
Breaking Biology News(10 mins):